X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Frontiers in Immunology

期刊標題檢索 FRONT IMMUNOL 最新評論: Instant rejection, may I ask the reason for the rejection? Is it due ... (2025-04-01)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Frontiers in Immunology]您好,您是該頁面的第 476399 位訪客。

期刊簡介
期刊名稱Frontiers in Immunology Frontiers in Immunology
LetPub Score
7.9
51 ratings
Rate

Reputation
7.8

Influence
7.3

Speed
8.5

期刊簡稱FRONT IMMUNOL
ISSN1664-3224
h-index84
CiteScore
CiteScoreSJRSNIPCiteScore Rank
9.801.8681.193
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Immunology and Allergy
Q152 / 233
Category: Medicine
Subcategory: Immunology
Q158 / 236

自引率 (2023-2024)8.80%自引率趨勢
掲載範囲
Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. Field Chief Editor Luigi Daniele Notarangelo is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.

Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis.
官方網站http://journal.frontiersin.org/journal/immunology
在線稿件提交http://www.frontiersin.org/submission/submissioninfo.aspx
開放訪問Yes
出版商Frontiers Media S.A.
主題領域IMMUNOLOGY
出版國/地區SWITZERLAND
發行頻率
創刊年0
每年文章數5971每年文章數趨勢
黃金OA百分比99.65%
OA Related Info
APC: Yes( USD3295; )
APC waiver:Check Notes
Other charges: No
Keywords: immunology、adaptive immunity、innate immunity、clinical immunology、molecular immunology
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ137/181
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1664-3224%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 14 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Frontiers in Immunology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    MMWR Recommendations and ReportsH-index: 0

    CiteScore: 36.00
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    學科內最受檢索的期刊 頁面查看次數
    BIOMATERIALS1200564
    Oncogenesis684013
    MEDICINE663191
    Frontiers in Pharmacology637427
    PHARMACEUTICAL BIOLOGY618142
    Cancer Medicine613699
    JOURNAL OF ETHNOPHARMACOLOGY595297
    Oncology Letters526043
    BIOMEDICINE & PHARMACOTHERAPY502566
    Journal of Materials Chemistry B477298
  •  

    Frontiers in Immunology Frontiers in Immunology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/80)
  [Frontiers in Immunology] 的評論撰寫評論
作者: HH G


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2025-04-01 14:42:25 評論於
Instant rejection, may I ask the reason for the rejection? Is it due to a fixed format? I noticed the first "principle of good faith" and it may be a problem of article repetition, with a 23% repetition rate. Most of the repetition is in the methods section. Do I need to make changes before resubmitting? I have requested detailed reasons for rejection from the editorial department, please help me out.
(0) 讚! | HH G

作者: wodetang


領域: 医学
審稿時間: 3.0 month(s)
結果: 待定&不明


撰寫評論

2025-03-29 09:45:37 評論於
May I ask what happened next?
(0) 讚! | wodetang

作者: wodetang


領域: 医学
審稿時間: 3.0 month(s)
結果: 待定&不明


撰寫評論

2025-03-28 14:05:36 評論於
May I ask if there have been any further developments?
(0) 讚! | wodetang

作者: BridgetWu


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-02-27 14:06:11 評論於
The editor has been assigned for more than ten days, but there has been no new action.
(0) 讚! | BridgetWu

作者: liuye


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-01-24 10:55:08 評論於
2025.1.3 Entered the production line process, initial assessment passed
2025.1.6 Agreed to reduce layout fees by 10%
2025.1.9 Paid layout fees
2025.1.13 Proofreading, the proofreader was very meticulous because there were many charts and the article was long, making the proofreading work complex. The proofreader made more than twenty proofreading suggestions, covering the entire article from title to references. It took several hours to carefully proofread and submit the proofread draft on the same day.
2025.1.21 The proof was reviewed and confirmed to be completed, and was scheduled for publication.
2025.1.23 Published.
(0) 讚! | liuye

作者: liuye


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-01-24 10:52:28 評論於
2025.1.3 Entered the production line process, initial evaluation passed.
2025.1.6 Agreed to reduce the layout fee by 10%.
2025.1.9 Paid the layout fee.
2025.1.13 Proofreading, the proofreading teacher is very careful, because there are many charts and the article is long, the proofreading work is complex. It may also be the reason for the late proofreading. The proofreading teacher proposed more than twenty proofreading suggestions, covering the entire article from title to references. Spent several hours carefully proofreading and submitted the proofreading draft on the same day.
2025.1.21 Proof confirmed and completed, scheduled for publication.
2025.1.23 Published.
(1) 讚! | liuye

作者: liuye


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-01-24 10:51:54 評論於
The magazine has a pretty fast pace, with publications coming out in less than three months from submission to acceptance. 

10/16: Submission
10/17: Request for original data
10/18: Resubmission, realizing original data was not translated, emailed magazine for re-submission
10/23: Magazine agrees
10/24: Resubmission
10/25: Initial Validation
10/26: Editorial Assignment
11/11: Independent Review
11/18: Major revisions based on first reviewer's feedback
11/20: Minor revisions based on third reviewer's feedback
11/25: Interactive Review, second reviewer disappears without submitting feedback
12/5: Submitted revised manuscript, first reviewer agrees to publication 36 minutes later
12/7: Second reviewer agrees to publication, enters Review Finalized stage
12/31: Editorial team changes, new editor requests manuscript to be revised and resubmitted according to reviewer feedback, despite already making previous revisions
1/2/2025: Enters Final Validation, accepted 1 hour later, initiates request for discount on publication fees on the system.
(0) 讚! | liuye

作者: duoduo


領域: 医学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2024-12-17 20:51:40 評論於
From submitting the paper starting from February 8th to being accepted in early June, it took about 4 months. There were a total of 3 reviewers who were quite diligent and responsible, providing many suggestions. We made gradual revisions based on their feedback, and ultimately the paper was successfully accepted!
(0) 讚! | duoduo

作者: 九嶷


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-12-12 04:33:14 評論於
What makes me most comfortable is that I can see the review comments of F company in real time, without having to wait for all the comments to come back and rush to make changes. I can make some changes in advance and the time for rework is still quite short, so there is room for adjustment.
(0) 讚! | 九嶷

作者: 九嶷


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-12-12 04:18:46 評論於
Brief review, the first attempt of an undergraduate student. The initial draft was not very good, but the editor gave me a chance to revise it several times. It took about 3 and a half months to be accepted, and another half a month to be published. It didn't feel as fast as others had mentioned. The review comments were 2224 4443, and the reviewer's feedback seemed very fair to me at my level.
(0) 讚! | 九嶷

作者: river1999


領域: 医学
審稿時間: 3.0 month(s)
結果: 拒稿


撰寫評論

2024-12-11 09:26:15 評論於
Wasted three months, three reviewers finally accepted two of them, and one provided some comments. Just as I was about to respond to the last comment, the editor suddenly rejected me... speechless.
(0) 讚! | river1999

作者: river1999


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-12-06 08:38:40 評論於
2024.11.22 Independent Review >>>  Interactive Review
2024.11.23 A new review report has been submitted by a Reviewer 4
05 Dec 2024 Submitting Author ...... posted new comments.
(1) 讚! | river1999

作者: river1999


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-28 13:36:36 評論於
Reviewer 2: 2 2 3 3 major revision
Reviewer 3: 3 3 4 4 major revision
Reviewer 4: 2 5 1 1 major revision
(0) 讚! | river1999

作者: river1999


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-28 13:36:18 評論於
2024.9.11 submit → Initial Validation
2024.9.12 Initial Validation → Editorial Assignment
2024.9.24 Editorial Assignment → Independent Review
2024.10.11 A new review report has been submitted by a Reviewer 2
2024.11.8 Reviewer 1 withdrawn
2024.11.18 A new review report has been submitted by a Reviewer 3
2024.11.22 Interactive review forum activated.
2024.11.23 A new review report has been submitted by a Reviewer 4
(0) 讚! | river1999

作者: hasuhasu


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-17 16:40:20 評論於
Excuse me, how long did the first step of the review take?
(0) 讚! | hasuhasu

作者: SCI中啊


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-11-14 21:26:29 評論於
From submission to acceptance, it took 4 months.
(0) 讚! | SCI中啊

作者: momo


領域: 医学
審稿時間: 12.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-12 11:45:01 評論於
I have been waiting for almost a month and still have not been assigned an editor.
(0) 讚! | momo

作者: xiaoleix


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-11-05 20:31:45 評論於
Please provide feedback for revisions within one month. Major revisions will be given two weeks, while minor revisions will be given one week. The final draft must be completed within 48 hours. The total time from submission to publication is two and a half months.
(0) 讚! | xiaoleix

作者: 宫古奥翔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-29 19:51:50 評論於
10.3 entered IR and it has been ongoing review with no changes.
(0) 讚! | 宫古奥翔

作者: 是你的荏苒呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-29 18:15:12 評論於
I am anxious to graduate.
(0) 讚! | 是你的荏苒呀

作者: 宫古奥翔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-29 18:11:28 評論於
It is best to choose possible editors when submitting a manuscript to Frontiers to expedite the process.
(0) 讚! | 宫古奥翔

作者: 是你的荏苒呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-29 15:17:51 評論於
I plan to rush the manuscript. Have you rushed the manuscript? I am eager to graduate.
(0) 讚! | 是你的荏苒呀

作者: 纯阳运乾


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-28 09:30:19 評論於
I'm almost 30 days into it, just like you, still in various states.
(0) 讚! | 纯阳运乾

作者: 天神院建元


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-27 23:42:34 評論於
Please translate the following paragraph into English: 接接接

"Connect, connect, connect"
(0) 讚! | 天神院建元

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-27 13:30:40 評論於
This stage generally tends to be relatively long, please be patient.
(0) 讚! | Adelaide Lawson

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/80)

開始撰寫 [Frontiers in Immunology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*